# MAXITROL

NDC: 0078-0771
Generic name: neomycin sulfate, polymyxin b sulfate and dexamethasone
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: OINTMENT
Routes: OPHTHALMIC
Marketing started: 19720117
Marketing ended: 20270228
FDA application: NDA050065

## Active ingredients

- DEXAMETHASONE: 1 mg/g
- NEOMYCIN SULFATE: 3.5 mg/g
- POLYMYXIN B SULFATE: 10000 [USP'U]/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0771"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0771
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22c6d2db-85af-4a3b-a014-80d901a86717